Glow Stack (GHK-Cu 50mg, TB-500 10mg, BPC-157 10mg)

The Glow Stack brings together three of the most extensively researched peptides in modern biomedicine in a single lyophilized preparation: GHK-Cu (50 mg), TB-500 (10 mg), and BPC-157 (10 mg). This combination was developed for research purposes to enable the investigation of synergistic interactions among three peptides with complementary mechanisms of action within a controlled experimental framework.

GHK-Cu, also known as copper peptide, is a naturally occurring tripeptide (Glycyl-L-Histidyl-L-Lysine) first isolated from human blood plasma in 1973. In its copper(II)-bound form, GHK-Cu demonstrates a remarkable capacity in research to modulate the expression of genes involved in collagen and elastin synthesis. Studies suggest that GHK-Cu influences the production of extracellular matrix proteins via the TGF-beta signaling pathway. With a half-life of approximately 12 hours, this copper peptide is particularly well suited for experimental designs requiring sustained exposure over extended periods. In the scientific literature, GHK-Cu has also been associated with antioxidant properties and the regulation of metalloproteinases.

TB-500 is a synthetic fragment of the endogenous protein Thymosin Beta-4, which is present in virtually all cell types. The central function of TB-500 in research lies in its effect on actin polymerization, a fundamental process governing cell structure and motility. Experimental data indicate that TB-500 can promote the migration of endothelial cells and keratinocytes, making it a significant subject of tissue regeneration research. The half-life of TB-500 is approximately 7 hours, allowing for flexible dosing schedules in research protocols.

BPC-157, formally known as Body Protection Compound-157, is a synthetic pentadecapeptide derived from a protective protein found in gastric juice. Preclinical studies have demonstrated that BPC-157 acts through the modulation of nitric oxide (NO) and the promotion of angiogenesis. With a shorter half-life of approximately 4 hours, BPC-157 exhibits rapid bioavailability, which is often accounted for in research through adjusted administration intervals. The scientific literature on BPC-157 now encompasses several hundred publications covering a wide range of experimental models.

The combination of these three peptides in the Glow Stack is of particular interest to researchers because their mechanisms of action operate on distinct yet interconnected biological levels. While GHK-Cu primarily targets the extracellular matrix and gene expression, TB-500 influences the cytoskeleton and cell migration, and BPC-157 modulates vascular and inflammation-related signaling pathways. This mechanistic complementarity makes the Glow Stack a valuable tool for multifactorial research approaches.

All three components are supplied as lyophilized powder with HPLC-confirmed purity of at least 99 percent. Lyophilization ensures excellent storage stability and allows for precise reconstitution with the solvent of choice. Each batch undergoes analysis by high-performance liquid chromatography and mass spectrometry to verify identity and purity. The Glow Stack is intended exclusively for research purposes and is not approved for human consumption. Researchers seeking to purchase a peptide stack that combines three complementary research peptides in a single preparation will find the Glow Stack a quality-assured solution for the scientific laboratory.